NCT05799612 2026-02-13
Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma
M.D. Anderson Cancer Center
Phase 1 Withdrawn
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
OHSU Knight Cancer Institute